EurekAlert (press release)CNIC scientists find the key to improved cancer immunotherapyEurekAlert (press release)The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell–one circu… Continue reading
Endpoints News |
FDA embraces the first US application for a gene therapy, offering an accelerated test case
Endpoints News If the approval does come through, Spark will be in the lead in establishing a reimbursement model for a gene therapy in a market dominated by multiple payers. UniQure tried and failed in Europe with Glybera and now GSK is following up making slow … Spark Therapeutics’ Biologics License Application for Investigational Voretigene Neparvovec Accepted for Filing by FDAGlobeNewswire (press release) |
Genetic Literacy Project |
DNA movies? Gene editor CRISPR used to store ‘movie’ in bacteria
Genetic Literacy Project Internet users have a variety of format options in which to store their movies, and biologists have now joined the party. Researchers have used the microbial immune system CRISPR–Cas to encode a movie into the genome of the bacterium Escherichia coli. CRISPR used to record a film in bacteriaBioNews |
The San Diego Union-Tribune |
Baby Boomers turn to stem cells for help with painful joints
The San Diego Union-Tribune Wallace and Sanford said they found that relief with stem cells; Wallace at UC San Diego using cells from his bone marrow, and Sanford at a clinic in Germany using cells from his fat tissue. Their cases — particularly Wallace’s — illustrate how the … |
|
This Is Why Investors Will Need to Learn a New Acronym: CRISPR
Motley Fool In this Market Foolery segment, host Chris Hill and Motley Fool Rule Breakers’ Aaron Bush talk about where genetic engineering is heading — which is out of the lab and toward really curing diseases. Yes, it’s early days. But the potential for CRISPR … |
|
Voyager Therapeutics (VYGR) Reports Publication of 2nd-Generation Gene Therapy Capsid Demonstrating Further …
StreetInsider.com “Key translational studies in non-human primates are underway by Voyager to evaluate these AAV variant capsids that have the potential to transform our ability to deliver gene therapies to the CNS. We are pleased to be partnered with the Gradinaru … |
|
Voyager Therapeutics (VYGR) Reports Publication of 2nd …
StreetInsider.com Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com’s Dividend Insider Elite. Sign-up for a … |